Arena Optimistic About Pipelined Insomnia Drug
Arena Pharmaceuticals has announced positive results for the Phase II clinical trials of APD125, a drug designed for patients with chronic insomnia.
Read MoreArena Pharmaceuticals has announced positive results for the Phase II clinical trials of APD125, a drug designed for patients with chronic insomnia.
Read MoreU. of Michigan researchers discover why opiate-based painkillers for fibromyalgia, a condition marked by pain, nausea, and fatigue, are often ineffective.
Read MoreA popular narcolepsy drug has been linked with at least five different skin diseases, according to the most recent FDA Drug Safety Newsletter.
Read MoreBoard of Registered Polysomnographic Technologists (BRPT) and the National Sleep Foundation (NSF) unveil Patients Guide to Sleep Evaluations.
Read MoreThe SAFER program did not improve sleep hygiene among medical interns.
Read More